CRISPR 2.0: a new wave of gene editors heads for clinical trials

FDA considers first CRISPR gene editing treatment that may cure sickle cell

UK becomes first country to approve Crispr gene-editing therapy

Big Pharma Wants to Use AI to Increase Diversity in Clinical Trials